The breaking of immune tolerance against autologous angiogenic endothelial
cells should be a useful approach for cancer therapy. Here we show that imm
unotherapy of tumors using fixed xenogeneic whole endothelial cells as a va
ccine was effective in affording protection from tumor growth, inducing reg
ression of established tumors and prolonging survival of tumor-bearing mice
. Furthermore, autoreactive immunity targeting to microvessels in solid tum
ors was induced and was probably responsible for the anti-tumor activity. T
hese observations may provide a new vaccine strategy for cancer therapy thr
ough the induction of an autoimmune response against the tumor endothelium
in a cross-reaction.